19 Feb 2010

United Therapeutics Corporation Withdraws European Marketing Authorization Application for Tyvaso for the Treatment of Pulmonary Arterial Hypertension

SILVER SPRING, Md., Feb. 19 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it has withdrawn its Marketing Authorization Application (MAA) for Tyvaso (treprostinil sodium)...

Download pdf

16 Feb 2010

United Therapeutics Corporation Reports 2009 Fourth Quarter and Annual Financial Results

SILVER SPRING, Md., Feb. 16 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the fourth quarter and year ended December 31, 2009. "We are pleased that...

Download pdf

10 Feb 2010

Lung Rx and ImmuneWorks Announce Collaboration in Idiopathic Pulmonary Fibrosis and Primary Graft Dysfunction

SILVER SPRING, Md., and INDIANAPOLIS, Feb. 10 /PRNewswire-FirstCall/ -- Lung Rx, LLC, a wholly-owned subsidiary of United Therapeutics Corporation (Nasdaq: UTHR), announced today that it has entered into a Development...

Download pdf

09 Feb 2010

United Therapeutics Corporation to Announce Fourth Quarter and Annual 2009 Financial Results Before Market Open on Tuesday, February 16, 2010

SILVER SPRING, Md., Feb. 9 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will release its fourth quarter and annual 2009 financial results before market open on Tuesday,...

Download pdf

23 Dec 2009

The Honorable Tommy G. Thompson Joins the United Therapeutics Corporation Board of Directors

SILVER SPRING, Md., Dec. 23 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today the appointment of the Honorable Tommy G. Thompson, former Secretary of the United States Department of...

Download pdf

29 Oct 2009

United Therapeutics Corporation Reports Third Quarter 2009 Financial Results

SILVER SPRING, Md., Oct. 29 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its results of operations for the quarter ended September 30, 2009. Revenues for...

Download pdf

22 Oct 2009

United Therapeutics Corporation to Announce Third Quarter 2009 Financial Results Before Market Open on Thursday, October 29, 2009

SILVER SPRING, Md., Oct. 22 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will release its 2009 third quarter financial results before market open...

Download pdf

01 Sep 2009

United Therapeutics Corporation Announces Stock Split To Be Effected as a Stock Dividend

SILVER SPRING, Md., Sept. 1 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that its Board of Directors has approved and declared a stock split. The stock...

Download pdf

31 Jul 2009

United Therapeutics Corporation Reports Second Quarter 2009 Financial Results

SILVER SPRING, Md., July 31 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its results of operations for the quarter ended June 30, 2009. Total revenues for...

Download pdf

30 Jul 2009

FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension

SILVER SPRING, Md., July 30 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that the United States Food and Drug Administration (FDA) has approved TYVASO...

Download pdf

24 Jul 2009

United Therapeutics Corporation to Announce Second Quarter 2009 Financial Results Before Market Open on Friday, July 31, 2009

SILVER SPRING, Md., July 24 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will release its 2009 second quarter financial results before market open...

Download pdf

09 Jun 2009

Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily

Data Findings Published in June Issue of CirculationSILVER SPRING, Md. and INDIANAPOLIS, June 9 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) and Eli Lilly and Company...

Download pdf